HEAVY METAL LOADING AND DETOXICATION PROTOCOL

Abstract

Physical, chemical and biological agents that damage a balanced biological system are called toxins.
Today, people are influenced by thousands of chemical and physical toxic substances that are acquired from soil, water, air and
food they take, which disrupt the cellular functions either in short or long term. Toxins can be taken from the outside or can occur
in the body after metabolic activities.
The body protects itself from these toxins through its detox systems with the help of physiological processes such as sweating, urine,
defecation, respiration and bile formation and the detoxification organs (intestines, kidneys, kidneys, etc.) where these processes
are carried out.
The role of heavy metals among the toxins is important. This article, in particular, places the Heavy Metals into the center and aims
to form a protocol for the elimination of heavy metals and other toxins.
 

Keywords

• Heavy Metal,Detox,Toxic.

AĞIR METAL YÜKLENMESİ VE ARINDIRMA PROTOKOLÜ

Abstract

Denge halindeki bir biyolojik sisteme zarar veren fiziksel, kimyasal ve biyolojik ajanlara toksin denir.
Günümüzde insanlar, topraktan, sudan, soludukları havadan ve aldıkları gıdalardan edinilen, hücresel fonksiyonları kısa ve uzun süreli
bozan, binlerce kimyasal ve fiziksel toksik ve zehirleyici maddelerin etkisi altında kalmaktadırlar. Toksinler dışarıdan alınabildikleri gibi,
vücutta metabolik faaliyetler sonrasında da oluşabilirler.
Vücut terleme, idrar, dışkılama, solunum ve safra oluşumu gibi fizyolojik süreçler ve bu süreçlerin gerçekleştirildiği detoksifikasyon
organlarının (barsaklar, karaciğeri böbrekler vs) yardımı ile kendini bu toksinlerden, kendi detoks sistemleri yoluyla korur
Toksinlerin arasında ağır metallerin yeri büyüktür. Bu makale, özellikle Ağır Metalleri merkezine almakta ve ağır metallerle oluşan
yüklenme ile onların eliminasyonları konusunda açılımda bulunmakta ve bir protokol oluşumuna yardımcı olmaktadır.
 

Keywords

• Ağır Metal,Detoks,Toksik.

References

1. 1. S.J.S. Flora, Megha Mittal , Ashish Mehta. Heavy metal induced oxidative stress & its possible reversal by chelation therapy. Indian J Med Res. October 2008; 128: 501-523. 2. James T. F. Wise, Lei Wang, Zhuo Zhang, Xianglin Shi. The 9th Conference on Metal Toxicity and Carcinogenesis: The Conference Overview. Toxicol Appl Pharmacol. 2017 Sep 15; 331:1–5. 3. Monisha Jaishankar, Tenzin Tseten, Naresh Anbalagan, Blessy B. Mathew, Krishnamurthy N. Beeregowda. Toxicity, mechanism and health effects of some heavy metals. Interdiscip Toxicol. 2014; 7(2): 60–72. 4. Oliver Ploss. Moderne Praxis bewährter Regulationstherapien - Entgiftung und Ausleitung, Säure-Basen-Haushalt, Darmsanierung. 4th edition. Stuttgart, New York, Delhi, Rio: Thieme Verlagsgruppe; 2017. Chapter 4, Entgiftung und Ausleitung; pp 32-49. 5. Joachim Mutter. Entgiftung: Effektiv bei vielen Krankheiten. OM – Zs. f. Orthomol. Med. 2016; 4: 5–15. 6. Wolfgang Marktl, Cem Ekmekcioglu, Bettina Reiter. Säuren-Basen- Schlacken. Vienna: Springer; 2007. Chapter 17, Kleef: Hypertermie und Entgiftung; pp 133-143. 7. Hüseyin Nazlıkul. Nöralterapi. Istanbul: Nobel Tıp Kitabevleri; 2010. Bölüm XII, Detoksifikasyon (Şelasyon) Nedir? Neden Gereklidir? pp 183- 196. 8. Denisse Diaz, Vivian Fonseca, Yamil W. Aude, Gervasio A. Lamas. Chelation therapy to prevent diabetes-associated cardiovascular events. Curr Opin Endocrinol Diabetes Obes. 2018 Aug; 25(4): 258–266. 9. Flora SJS and Pachauri V. Chelation in Metal Intoxication. International Journal of Environmental Research and Public Health. 2010;7(7):2745- 2788. doi:10.3390/ijerph7072745. 10. Sujit Sheth. Iron chelation: an update. Current Opinion In Hematology. 2014; 21 (00): 1-7. 11. Elham Zeini Jahromi and Jürgen Gailer. Improved selectivity of ZnNa3DTPA vs. Na5DTPA to abstract Cd2+ from plasma proteins in vitro. Metallomics, 2013; 5: 615—61. 12. Martin F.H.K. Klehmet. Chroniker und Metallbelastungen aus der Mundhöhle. Zs.f.Orthomol. Med. 2018; 16(03): 11-15. 13. John B. Porter, Michael Evangeli, Amal El-Beshlawy. The challenges of adherence and persistence with iron chelation therapy. Int J Hematol. 2011; 94:453–460. 14. Jabbour E, Garcia-Manero G, Taher A, Kantarjian HM. Managing iron overload in patients with myelodysplastic syndromes with oral deferasirox therapy. Oncologist. 2009;14:489–96. 15. Cappellini MD. Overcoming the challenge of patient compliance with iron chelation therapy. Semin Hematol. 2005;42:S19–21.